Kramps, Thomas

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

Petsch, B., Schnee, M., Vogel, A. B., Lange, E., Hoffmann, B., Voss, D., Schlake, T., Thess, A., Kallen, K.-J., Stitz, L., et al. (2012) · Nature Biotechnology

Influenza Virus Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 464

An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs

Schnee, M., Vogel, A. B., Voss, D., Petsch, B., Baumhof, P., Kramps, T., & Stitz, L. (2016) · PLOS Neglected Tropical Diseases

Rabies epidemiology and controlVirology and Viral Diseases

Cited by 212

A thermostable messenger RNA based vaccine against rabies

Stitz, L., Vogel, A., Schnee, M., Voss, D., Rauch, S., Mutzke, T., Ketterer, T., Kramps, T., & Petsch, B. (2017) · PLOS Neglected Tropical Diseases

Rabies epidemiology and controlRNA Interference and Gene Delivery

Cited by 117

Messenger RNA‐based vaccines: progress, challenges, applications

Kramps, T., & Probst, J. (2013) · WIREs RNA

Immunotherapy and Immune ResponsesRNA Interference and Gene Delivery

Cited by 50

Modelling of patient journey in chronic spontaneous urticaria: Increasing awareness and education by shorten patients' disease journey in Germany

Maurer, M., Augustin, M., Bauer, S., Ekanayake‐Bohlig, S., Kircher, P., Knöll, A., Kramps, T., Kurzen, H., Laemmel, S., Novak, N., et al. (2024) · Journal of the European Academy of Dermatology and Venereology

Urticaria and Related ConditionsChronic Disease Management Strategies

Cited by 15